A new triple-action weekly jab for type 2 diabetes could significantly reduce blood sugar and body weight, according to phase 3 trial results Patients
Anna Bawden is a Health and Social Affairs Correspondent at various prominent outlets. She covers a wide range of topics including medicine and healthcare, wellness, climate change, and beauty, with a particular focus on health news, drugs and medication, oncology, and fitness. Anna's work has been featured in Knowledia, Yahoo Sports Canada, Yahoo News UK, AOL UK, The Guardian, Daily Climate, The Irish Times, Irish Examiner, and MSN.






